Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Valeant hands off its controversial, $1B female libido drug to Sprout backers in sweetheart deal
Valeant hands off its controversial, $1B female libido drug to Sprout backers in sweetheart deal
Valeant hands off its controversial, $1B female libido drug to Sprout backers in sweetheart deal
Submitted by
admin
on November 6, 2017 - 9:07am
Source:
Endpoints
News Tags:
Valeant Pharmaceuticals
Addyi
female sexual dysfunction
Sprout Pharmaceuticals
Headline:
Valeant hands off its controversial, $1B female libido drug to Sprout backers in sweetheart deal
Do Not Allow Advertisers to Use My Personal information
